Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TetraGenetics
Cambridge, Massachusetts, United Statestetragenetics.com ↗
- Ownership
- Private
- Employees
- ~11
- Development stage
- Other
01
Overview
TetraGenetics has developed a proprietary platform enabling the high-yield production of functional, complex recombinant transmembrane proteins such as ion channels and GPCRs for antibody discovery against difficult-to-drug targets. Its work underpins drug discovery for autoimmune diseases and pain but has not advanced to clinical-stage programs itself
- Therapeutic areas
- ImmunologyNeurologyOther
- Modalities
- Recombinant proteinAntibody
- Industry
- Drug Discovery Services
02
Partnerships
AbCellera (parent company)Partnerships with pharmaceutical/biotech companies using the platform for antibody discovery (historically, e.g., Heptares Therapeutics for GPCR projects)
Beyond the preview
Go deeper on TetraGenetics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TetraGenetics.